Numbers:
I saw it as well. Quite interesting in MSD look at all small biotechs in Australia, ( and elsewhere throughout the world) and develop a checklist of companies they're interested in, and keep those companies under observation, so to speak.
So SUDA would have been in their spotlight at some time, if this is accurate. MSD seem to be more interested in new drugs in development, rather than a unique delivery method. This is the company that bought Aussie biotech Vitalytics? for $500 million in the past few months. So there is interest and also money for T/O's.
Just gotta get the right formula and show signs of onward development to inspire interest.
This is why I still believe there is a chance for SUDA, with its Hydrotrope IP.
Article in todays Australian page 17, page-2
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.5¢ |
Change
-0.005(3.33%) |
Mkt cap ! $152.5M | |||
| Open | High | Low | Value | Volume |
| 14.8¢ | 15.0¢ | 14.3¢ | $303.9K | 2.087M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 202037 | 14.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.0¢ | 320045 | 4 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| ALA (ASX) Chart |